Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

OMKAR PHARMACHEM vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    OMKAR PHARMACHEM LUPIN OMKAR PHARMACHEM/
LUPIN
 
P/E (TTM) x 125.3 -14.6 - View Chart
P/BV x 2.5 2.6 96.9% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 OMKAR PHARMACHEM   LUPIN
EQUITY SHARE DATA
    OMKAR PHARMACHEM
Mar-21
LUPIN
Mar-22
OMKAR PHARMACHEM/
LUPIN
5-Yr Chart
Click to enlarge
High Rs211,268 1.6%   
Low Rs16679 2.3%   
Sales per share (Unadj.) Rs0.3361.0 0.1%  
Earnings per share (Unadj.) Rs0.2-33.2 -0.7%  
Cash flow per share (Unadj.) Rs0.23.3 6.7%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Avg Dividend yield %00.4 0.0%  
Book value per share (Unadj.) Rs8.6263.9 3.3%  
Shares outstanding (eoy) m10.08454.48 2.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x68.42.7 2,535.6%   
Avg P/E ratio x83.3-29.3 -284.4%  
P/CF ratio (eoy) x82.9296.8 27.9%  
Price / Book Value ratio x2.13.7 57.8%  
Dividend payout %0-12.0 0.0%   
Avg Mkt Cap Rs m185442,238 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m129,893 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3164,055 0.0%  
Other income Rs m02,137 0.0%   
Total revenues Rs m3166,192 0.0%   
Gross profit Rs m02,152 0.0%  
Depreciation Rs m016,587 0.0%   
Interest Rs m11,428 0.0%   
Profit before tax Rs m0-13,726 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-31,372 -0.2%   
Profit after tax Rs m2-15,097 -0.0%  
Gross profit margin %8.11.3 615.4%  
Effective tax rate %714.7-10.0 -7,152.8%   
Net profit margin %82.0-9.2 -891.1%  
BALANCE SHEET DATA
Current assets Rs m1124,577 0.0%   
Current liabilities Rs m1082,764 0.0%   
Net working cap to sales %-332.125.5 -1,303.1%  
Current ratio x0.11.5 4.9%  
Inventory Days Days12,57233 37,967.7%  
Debtors Days Days36595 384.9%  
Net fixed assets Rs m9391,938 0.1%   
Share capital Rs m101909 11.1%   
"Free" reserves Rs m-14119,006 -0.0%   
Net worth Rs m87119,915 0.1%   
Long term debt Rs m01,419 0.0%   
Total assets Rs m94216,515 0.0%  
Interest coverage x0.4-8.6 -4.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x00.8 3.8%   
Return on assets %3.0-6.3 -47.0%  
Return on equity %2.6-12.6 -20.3%  
Return on capital %0.2-10.1 -2.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m053,594 0.0%   
Fx outflow Rs m038,143 0.0%   
Net fx Rs m015,451 0.0%   
CASH FLOW
From Operations Rs m03,673 0.0%  
From Investments Rs mNA12,922 0.0%  
From Financial Activity Rs mNA-15,723 0.0%  
Net Cashflow Rs m0872 0.0%  

Share Holding

Indian Promoters % 0.0 46.8 0.1%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 0.0 41.5 -  
FIIs % 0.0 14.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 100.0 52.9 189.0%  
Shareholders   3,561 382,828 0.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare OMKAR PHARMACHEM With:   DR. REDDYS LAB    SUN PHARMA    CIPLA    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    



Today's Market

Sensex Tanks 652 Points, Nifty Ends Below 17,800; IndusInd Bank & Bajaj Finserv Top Losers(Closing)

After opening the day on a flat note, Indian share markets turned volatile during the afternoon session and fell hard as selling was seen in banking and auto stocks.